Trimetazidine dihydrochloride (Vastarel F) can improve myocardial glucose utilization by inhibiting fatty acid metabolism. Trimetazidine is the first cytoprotective anti-ischemic agent, also used as a vasodilator in ischemic heart disease or angina.
Molecular Weight:
339.258
CAS Number:
[13171-25-0]
Formula:
C14H24Cl2N2O3
Target:
Autophagy|||Fatty Acid Synthase
* VAT and and shipping costs not included. Errors and price changes excepted